Fungal antioxidant pathways promote survival against neutrophils during infection

Journal of Clinical Investigation

Volumn 122, Issue 7, 2012, Pages 2482-2498

  Leal, Sixto M ^a   Vareechon, Chairut ^a   Cowden, Susan ^b   Cobb, Brian A ^a   Latgé, Jean Paul ^c   Momany, Michelle ^b   Pearlman, Eric ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD18 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; DECTIN 1; EXTRACELLULAR SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; PX 12; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOREDOXIN; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CORNEA OPACITY; ENZYME ACTIVATION; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS HYPHAE; FUSARIOSIS; FUSARIUM OXYSPORUM; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATOMYCOSIS; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 84863558332     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63239     Document Type: Article

References (79)

1. Milner JD, Sandler NG, Douek DC. Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS. 2010;5(2):179-183.
2. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect. 2010;16(9):1335-1342.
3. Thomas PA. Fungal infections of the cornea. Eye. 2003;17(8):852-862. (Pubitemid 37541037)
4. Gower EW, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117(12):2263-2267.
5. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90(1):38-47. (Pubitemid 10033930)
6. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101(6):1005-1013. (Pubitemid 24183155)
7. Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113(11):1943-1948. (Pubitemid 44635704)
8. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14(2):61-69. (Pubitemid 46676497)
9. Bhartiya P, Daniell M, Constantinou M, Islam FM, Taylor hour Fungal keratitis in Melbourne. Clin Experiment Ophthalmol. 2007;35(2):124-130. (Pubitemid 46390801)
10. Dunlop AA, et al. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994;22(2):105-110. (Pubitemid 24270343)
11. Saha R, Das S. Mycological profile of infectious keratitis from Delhi. Indian J Med Res. 2006; 123(2):159-164.
12. Perez-Balbuena AL, Vanzzini-Rosano V, Valadez-Virgen Jde J, Campos-Moller X. Fusarium keratitis in Mexico. Cornea. 2009;28(6):626-630.
13. Chang DC, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296(8):953-963. (Pubitemid 44285372)
14. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15(4):321-327. (Pubitemid 38962112)
15. Prajna NV, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128(6):672-678.
16. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol. 2006;6(7):541-550. (Pubitemid 43980526)
17. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev. 2007;219:88-102. (Pubitemid 47390004)
18. Karthikeyan RS, et al. Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium. J Infect Dis. 2011;204(6):942-950.
19. Leal SM Jr, Cowden S, Hsia YC, Ghannoum MA, Momany M, Pearlman E. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog. 2011;6:e1000976.
20. Tarabishy AB, et al. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J Immunol. 2008;181(1):593-600.
21. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol. 2008;4(5):278-286. (Pubitemid 351550893)
22. Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol. 2009;47(suppl 1):S282-290.
23. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med. 1997;185(2):207-218. (Pubitemid 27078278)
24. Pollock JD, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995;9(2):202-209.
25. Philippe B, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun. 2003;71(6):3034-3042. (Pubitemid 36637524)
26. Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis. 1990;162(2):523-528. (Pubitemid 20239974)
27. Henriet SS, et al. Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms. Infect Immun. 2011;79(2):767-773.
28. Faust N, Varas F, Kelly LM, Heck S, Graf T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood. 2000;96(2):719-726. (Pubitemid 30463397)
29. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008;48:171-197. (Pubitemid 351756361)
30. Wilson RW, et al. Gene targeting yields a CD18- mutant mouse for study of inflammation. J Immunol. 1993;151(3):1571-1578. (Pubitemid 23219295)
31. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4(3):181-189. (Pubitemid 38339084)
32. Andrews T, Sullivan KE. Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev. 2003;16(4):597-621. (Pubitemid 37296551)
33. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol. 2008;30(3):279-289.
34. Hohl TM, et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific betaglucan display. PLoS Pathog. 2005;1(3):e30.
35. van Bruggen R, et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol Immunol. 2009;47(2-3):575-581.
36. Lessing F, et al. The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model. Eukaryot Cell. 2007;6(12):2290-2302.
37. Lambou K, Lamarre C, Beau R, Dufour N, Latge JP. Functional analysis of the superoxide dismutase family in Aspergillus fumigatus. Mol Microbiol. 2010;75(4):910-923.
38. Paris S, et al. Catalases of Aspergillus fumigatus. Infect Immun. 2003;71(6):3551-3562. (Pubitemid 36637584)
39. Fallon JP, Reeves EP, Kavanagh K. Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J Med Microbiol. 2010;59(pt 6):625-633.
40. Tsunawaki S, Yoshida LS, Nishida S, Kobayashi T, Shimoyama T. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun. 2004;72(6):3373-3382. (Pubitemid 38697762)
41. Perrin RM, et al. Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA. PLoS Pathog. 2007;3(4):e50.
42. Qiao J, et al. Afyap1, encoding a bZip transcriptional factor of Aspergillus fumigatus, contributes to oxidative stress response but is not essential to the virulence of this pathogen in mice immunosuppressed by cyclophosphamide and triamcinolone. Med Mycol. 2008;46(8):773-782.
43. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003;28(1):32-40. (Pubitemid 36051004)
44. Koharyova M, Kolarova M. Oxidative stress and thioredoxin system. Gen Physiol Biophys. 2008;27(2):71-84.
45. Glaser AG, Menz G, Kirsch AI, Zeller S, Crameri R, Rhyner C. Auto- and cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis. Allergy. 2008;63(12):1617-1623.
46. Ramanathan RK, et al. A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy [published online ahead of print August 24, 2011]. Invest New Drugs. doi:10.1007/s10637-011-9739- 9.
47. Ramanathan RK, et al. A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clin Cancer Res. 2007;13(7):2109-2114. (Pubitemid 46649879)
48. Welsh SJ, Williams RR, Birmingham A, Newman DJ, Kirkpatrick DL, Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Mol Cancer Ther. 2003;2(3):235-243.
49. Ramanathan RK, et al. A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. Cancer Chemother Pharmacol. 2011;67(3):503-509.
50. Chauhan N, Latge JP, Calderone R. Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus. Nat Rev Microbiol. 2006;4(6):435-444. (Pubitemid 43771863)
51. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med. 2003;197(9):1119-1124. (Pubitemid 36570067)
52. Vetvicka V, Thornton BP, Ross GD. Soluble betaglucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest. 1996;98(1):50-61. (Pubitemid 26243820)
53. Lavigne LM, Albina JE, Reichner JS. Beta-glucan is a fungal determinant for adhesion-dependent human neutrophil functions. J Immunol. 2006;177(12):8667-8675. (Pubitemid 44893831)
54. Boyle KB, et al. Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae. J Immunol. 2011;186(5):2978-2989.
55. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol. 2009;27:339-362.
56. Leal SM Jr, Cowden S, Hsia YC, Ghannoum MA, Momany M, Pearlman E. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog. 2010;6:e1000976.
57. Werner JL, et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol. 2009;182(8):4938-4946.
58. Goodridge HS, et al. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature. 2011;472(7344):471-475.
59. Vedder NB, Harlan JM. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest. 1988;81(3):676-682. (Pubitemid 18079714)
60. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012;f30:459-489.
61. Goodridge HS, Wolf AJ, Underhill DM. Betaglucan recognition by the innate immune system. Immunol Rev. 2009;230(1):38-50.
62. Mocsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387-402.
63. Chai LY, et al. Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses. Microbes Infect. 2011;13(2):151-159.
64. Netea MG, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest. 2006;116(6):1642-1650.
65. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826-837.
66. Chun KH, Seong SY. CD14 but not MD2 transmit signals from DAMP. Int Immunopharmacol. 2010;10(1):98-106.
67. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011;7(8):504-511.
68. Aratani Y, et al. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus. Med Mycol. 2002;40(6):557-563. (Pubitemid 36050146)
69. Elahi S, Pang G, Ashman RB, Clancy R. Nitric oxide-enhanced resistance to oral candidiasis. Immunology. 2001;104(4):447-454. (Pubitemid 34037838)
70. de Jesus-Berrios M, Liu L, Nussbaum JC, Cox GM, Stamler JS, Heitman J. Enzymes that counteract nitrosative stress promote fungal virulence. Curr Biol. 2003;13(22):1963-1968. (Pubitemid 37425205)
71. Bahn YS, Sundstrom P. CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans. J Bacteriol. 2001;183(10):3211- 3223. (Pubitemid 32433540)
72. Sugui JA, et al. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One. 2008;3(7):e2655.
73. Thon M, Al-Abdallah Q, Hortschansky P, Brakhage AA. The thioredoxin system of the filamentous fungus Aspergillus nidulans: impact on development and oxidative stress response. J Biol Chem. 2007;282(37):27259-27269. (Pubitemid 47501931)
74. Spikes S, et al. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis. 2008;197(3):479-486. (Pubitemid 351263432)
75. Belkacemi L, Barton RC, Hopwood V, Evans EG. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection. Med Mycol. 1999;37(4):227-233. (Pubitemid 29364138)
76. Chapman RW, Phillips JE, Hipkin RW, Curran AK, Lundell D, Fine JS. CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol Ther. 2009;121(1):55-68.
77. Sugui JA, et al. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell. 2007;6(9):1562-1569. (Pubitemid 47483599)
78. Bok JW, et al. GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence. Infect Immun. 2006;74(12):6761-6768. (Pubitemid 44913150)
79. Kale SP, Milde L, Trapp MK, Frisvad JC, Keller NP, Bok JW. Requirement of LaeA for secondary metabolism and sclerotial production in Aspergillus flavus. Fungal Genet Biol. 2008;45(10):1422-1429.